Two-dimensional electrophoretic protein profile analysis following exposure of human uroepithelial cells to occupational bladder carcinogens

Cancer Letters

Volumn 205, Issue 2, 2004, Pages 121-131

  Kanitz, Mary Helen ^a   Swaminathan, Santhanam ^b   Savage Jr , Russell E ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Bladder carcinogen; Protein biomarkers; Two dimensional gel electrophoresis; Uroepithelial cells

Indexed keywords

AMINO ACID; ANILINE DERIVATIVE; BIOLOGICAL MARKER; CARCINOGEN; HYDROXYL GROUP; N HYDROXY 4 BIPHENYLAMINE; N HYDROXY 4,4' METHYLENEBIS(2 CHLOROANILINE); PHENYL GROUP; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BLADDER; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DATA BASE; EPITHELIUM CELL; EXPOSURE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; TWO DIMENSIONAL ELECTROPHORESIS;

EID: 1242293678     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2003.09.032     Document Type: Article

References (38)

1. Wingo P.A., Tong T., Bolden S. Cancer statistics. CA J. Clin. 45:1995;8-30.
2. Rubben H., Lutzeyer W., Wallace D.M.A. The epidemiology and etiology of bladder cancer. Zingg E.J., Wallace D.M.A. Bladder Cancer. 1985;3-49 Springer, New York.
3. Torti F.M., Lum B.L. The biology and treatment of superficial bladder cancer. J. Clin. Oncol. 2:1984;505-531.
4. Abel P.D. Prognostic indices in transitional cell carcinoma of the bladder. Br. J. Urol. 62:1988;103-109.
5. Cancer Facts and Figures. Publ. 95-375M-No5008.95. 1995;ACS, Atlanta, GA.
6. Silverman D.T., Hartget P., Morrison A.S. Epidemiology of bladder cancer. Hematol. Oncol. Clin. North Am. 6:1992;1-30.
7. Bookland E.A., Swaminathan S., Gilchrist K.W., Oyasu R., Reznikoff C.A. Tumorigenic transformation and neoplastic progression of human uroepithelial cells after exposure in vitro to 4-aminobiphenyl or its metabolites. Cancer Res. 32:1992;1606-1614.
8. Reznikoff C.A., Kao C., Messing E.M., Newton M., Swaminathan S. A molecular model of human bladder carcinogenesis. Sem. Cancer Biol. 4:1993;143-152.
9. Christian B.J., Loretz L.J., Oberley T.D., Reznikoff C.A. Characterization of human uroepithelial cells immortalized in vitro by simian virus 40. Cancer Res. 47:1987;6066-6073.
10. Savage R.E. Jr., DeBord D.G., Swaminathan S., Butler M.A., Snawder J., Kanitz M.H., et al. Occupational applications of a human cancer research model. J. Occup. Environ. Med. 40:1998;125-135.
11. Perera F.P. Molecular cancer epidemiology: a new tool in cancer preventions. J. Natl. Cancer Inst. 78:1987;887-898.
12. Nicolson G.L. Gene expression, cellular diversification and tumor progression to the metastatic phenotype. BioEssays. 13:1991;337-342.
13. Rehn L. Blasengeschwulste bei Anilinarbeitern. Arch. Klin. Chir. 50:1895;588-600.
14. Kuller L.H., Garfinkel L., Correa P., Haley N., Hoffmann D., Preston-Martin S., Sandler D. Contribution of passive smoking to respiratory cancer. Environ. Health Perspect. 70:1986;56-69.
15. Haugen D.A., Peak M.J., Shuhrbler K.M., Stamoudis V.C. Isolation of mutagenic aromatic amines from a coal conversion oil by cationic exchange chromatography. Anal. Chem. 54:1982;32-37.
16. Melick W.F., Naryka J.J., Kelly R.E. Bladder cancer due to exposure to para-aminobiphenyl: a 17-year follow-up. J. Urol. 106:1971;220-226.
17. Swaminathan S., Hatcher J.F. Identification of new DNA adducts in human bladder epithelia exposed to the proximate metabolite of 4-aminobiphenyl using 32P-postlabeling method. Chem. Biol. Interact. 139:2002;199-213.
18. Hatcher J.F., Swaminathan S. Detection of deoxyadenosine-4-aminobiphenyl adduct in DNA of human uroepithelial cells treated with N-hydroxy-4- aminobiphenyl following nuclease P1 enrichment and P32-postlabeling analysis. Carcinogenesis. 16:1995;295-301.
19. 32P-Postlabeling analyses of DNA damage in human uroepithelial cells exposed to proximate metabolites of the environmental carcinogen 4-aminobiphenyl. Environ. Mol. Mutagen. 39:2002;314-322.
20. Talaska G., Schamer M., Skipper P., Tannenbaum S., Caporaso N., Unruh L., et al. Detection of carcinogen-DNA adducts in exfoliated urothelial cells of cigarette smokers: association with smoking, hemoglobin adducts, and urinary mutagenicity. Cancer Epidemiol. Biomarkers Prev. 1:1991;61-66.
21. Kadlubar F.F., Beland F.A. Chemical properties of ultimate carcinogenic metabolites of arylamines and arylamides. Harvey R.G. Polycyclic Hydrocarbons and Carcinogenesis. 1985;341-370 ACS Press, Washington, DC.
22. The International Agency for Research on Cancer, Suppl. 7, 91 (1987) 1-42.
23. McQueen C.A., Williams G.A. Review of the genotoxicity and carcinogenicity of 4,4′-methylene-dianiline and 4,4′-methylene-bis- 2-chloroaniline. Mutat. Res. 239:1990;133-142.
24. Morton K.C., Lee M.-S., Siedlik P., Chapman R. Metabolism of 4,4′methylene-bis2chloroaniline (MOCA) by rats in vivo and formation of N-hydroxy MOCA by rat and human liver microsomes. Carcinogenesis. 9:1988;731-739.
25. Kadlubar F.F., Miller J.A., Miller E.C. Hepatic microsomal N-glucuronidation and nucleic acid binding of N-hyroxyarlamines in relation to urinary bladder carcinogenesis. Cancer Res. 37:1977;805-814.
26. 32P-postlabeling assay. Fundam. Appl. Toxicol. 30:1996;138-144.
27. Swaminatham S., Frederickson S.M., Hatcher J.F., Reznikoff C.A., Butler M.A., Cheever K.L., Savage R.E. Jr. Neoplastic transformation and DNA binding of 4,4′-methylenebis(2-chloroaniline) in SV-40-immortalized human uroepithelial cell lines. Carcinogenesis. 17:1996;857-864.
28. Swaminathan S., Reznikoff C. Biochemical and molecular carcinogenesis. Vogelzang N.J., Scardino P.T., Shipley M.U., Coffey D.S. Comprehensive Textbook of Genitourinary Oncology. 2000;289-297 Williams & Wilkins, Baltimore, MD.
29. Meisner L.F., Wu S.-Q., Christian B.J., Reznikoff C.A. Cytogenetic instability with balanced chromosome changes in an SV40 transformed human uroepithelial cell line. Cancer Res. 48:1988;3215-3220.
30. Pratt C.I., Oyasu R., Reznikoff C.A. Neoplastic progression by EJ/ras at different steps of transformation in vitro of human uroepithelial cells. Cancer Res. 52:1992;688-695.
31. Chen T.H., Kuslikis B.I., Braselton W. Jr. Hydroxylation of 4,4′methylenebis (2-chloroaniline) by canine, guinea pig and rat liver microsomes. Drug Metab. Dispos. 17:1989;406-413.
32. S.L. Tollaksen, N.L. Anderson, N.G. Anderson, Operation of the ISO-DALT System, 7th ed., US Dept. Energy Publ. ANL-BIM-84-1, US Department of Energy, Argonne, IL, 1984.
33. Miller M.J., Schwartz D.M., Thorgeirsson S.S. Inter- and intraclonal variability of polypeptides synthesized in a rat hepatoma cell line: quantitative two-dimensional gel analysis. J. Biol. Chem. 263:1988;11227-11236.
34. Celis J.E., Celis P., Ostergaard M., Basse B., Lauridsen J.B., Rasmussen H.H., et al. Proteomics and immunochemistry define some of the steps in the squamous differentiation of the bladder transitional epithelium: a novel strategy for identifying metaplastic lesions. Cancer Res. 59:1999;3003-3009.
35. Celis A., Rasmussen H.H., Celis P., Basse B., Lauridsen J.B., Ratz G., et al. Short-term culturing of low grade superficial bladder transitional cell carcinoma leads to changes in the expression levels of several proteins involved in key cellular activities. Electrophoresis. 20:1999;355-361.
36. Celis J.E., Ostergaard M., Basse B., Celis A., Lauridsen J.B., Ratz G.P., et al. Loss of adipocyte-type fatty acid binding protein and other protein biomarkers is associated with progression of human bladder transitional cell carcinomas. Cancer Res. 56:1996;4782-4790.
37. Strange R.C., Spiteri M.A., Ramachandran S., Fryer A. Glutathione-S-transferase family of enzymes. Mutat. Res./Fundam. Mol. Mech. Mutagenesis. 482:2001;21-26.
38. Adler V., Yin Z., Fuchs S.Y., Benezra M., Rosario L., Tew K.D., et al. Regulation of JNK signalling by GSTp. Eur. Mol. Biol. Org. J. 18:1999;1321-1334.